COVAXIN Price

Overview

Welcome to Dwaey, specifically on COVAXIN page.
This medicine contains an important and useful components, as it consists of
Whole Virion, Inactivated Coronavirus Antigen (Strain: NIV-2020-770) is available in the market in concentration

Name

Almotriptan

Precaution

- **Cardiovascular Risks**: Almotriptan can cause serious cardiovascular events, including myocardial infarction, life-threatening arrhythmias, and stroke. It should be used with caution in patients with a history of heart disease, high blood pressure, high cholesterol, or other cardiovascular conditions. Regular monitoring of heart health is essential while taking almotriptan. - **Serotonin Syndrome**: Almotriptan can cause serotonin syndrome, a potentially life-threatening condition that occurs when there is too much serotonin in the brain. Symptoms include agitation, hallucinations, coma, and changes in blood pressure. This risk is higher when almotriptan is used with other serotonergic drugs, such as selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs). - **Medication Overuse Headache**: Overuse of almotriptan can lead to medication overuse headache, a condition where frequent use of headache medications causes more headaches. It is important to follow the prescribed dosage and not exceed the recommended number of tablets per month. - **Allergic Reactions**: Almotriptan can cause allergic reactions, including anaphylaxis, a severe and potentially life-threatening reaction. Symptoms include hives, difficulty breathing, and swelling of the face, lips, tongue, or throat. Seek immediate medical attention if you experience these symptoms. - **Renal and Hepatic Impairment**: Patients with kidney or liver disease should use almotriptan with caution, as it is primarily eliminated by the kidneys and liver. Dose adjustments may be necessary for these patients to avoid accumulation of the drug in the body. - **Pregnancy and Breastfeeding**: The safety of almotriptan during pregnancy and breastfeeding has not been established. It should be used only if the potential benefits outweigh the risks. Consultation with a healthcare provider is essential before use. - **Drug Interactions**: Almotriptan can interact with other medications, including ergot-containing drugs, other triptans, and certain antidepressants. These interactions can increase the risk of side effects or reduce the effectiveness of almotriptan. Always inform your doctor about all medications you are taking. - **High Blood Pressure**: Almotriptan can cause an increase in blood pressure. Patients with uncontrolled high blood pressure should use almotriptan with caution and monitor their blood pressure regularly. - **Seizures**: Almotriptan should be used with caution in patients with a history of seizures, as it can lower the seizure threshold. Close monitoring is essential for these patients while taking almotriptan. - **Elderly Patients**: Elderly patients may be more sensitive to the effects of almotriptan, including an increased risk of side effects. Close monitoring is essential for elderly patients taking almotriptan.

Indication

- **Acute Migraine Treatment**: Almotriptan is primarily used to treat acute migraine headaches with or without aura in adults and adolescents aged 12 and older. It is effective in relieving migraine symptoms, including pain, nausea, and sensitivity to light and sound. - **Cluster Headaches**: While almotriptan is not typically used for cluster headaches, it may be prescribed off-label for this condition in some cases. Cluster headaches are a series of relatively short but extremely painful headaches that occur in groups or cycles. - **Migraine with Aura**: Almotriptan can be used to treat migraines that are accompanied by an aura, which is a warning sign that a migraine is about to begin. Auras can include visual disturbances, such as flashing lights or blind spots, and other sensory changes. - **Migraine without Aura**: Almotriptan is also effective in treating migraines that occur without an aura. These migraines can cause severe throbbing pain, nausea, and sensitivity to light and sound. - **Migraine in Adolescents**: Almotriptan is approved for use in adolescents aged 12 and older who experience migraines. It is particularly beneficial for adolescents with a history of migraines that last four hours or longer when left untreated. - **Migraine in Adults**: Almotriptan is a first-line treatment for acute migraine attacks in adults. It helps to alleviate migraine symptoms quickly and effectively, allowing patients to return to their daily activities. - **Migraine with Nausea**: Almotriptan can help alleviate nausea associated with migraines. It works by blocking the release of certain natural substances that cause pain, nausea, and other migraine symptoms. - **Migraine with Sensitivity to Light and Sound**: Almotriptan is effective in reducing sensitivity to light and sound, which are common symptoms of migraines. It helps to alleviate these sensitivities, making it easier for patients to function during a migraine attack. - **Migraine with Long Duration**: Almotriptan is beneficial for patients who experience migraines that last for extended periods. It helps to shorten the duration of migraine attacks and reduce the severity of symptoms. - **Migraine with Severe Pain**: Almotriptan is used to treat migraines that cause severe, throbbing pain. It works by narrowing blood vessels around the brain and stopping pain signals from being sent to the brain.

Contra indication

- **Hypersensitivity**: Almotriptan is contraindicated in patients with a known hypersensitivity to almotriptan or any of its components. Allergic reactions can manifest as skin rashes, itching, or difficulty breathing. - **Cardiovascular Disease**: Patients with a history of heart disease, including coronary artery disease, angina, heart attack, or other cardiovascular conditions, should avoid almotriptan due to the risk of serious cardiovascular events. - **Cerebrovascular Disease**: Patients with a history of stroke or transient ischemic attacks (TIAs) should not use almotriptan, as it can increase the risk of cerebrovascular events. - **Peripheral Vascular Disease**: Patients with peripheral vascular disease, which affects blood flow to the extremities, should avoid almotriptan due to the risk of exacerbating symptoms. - **Uncontrolled Hypertension**: Patients with uncontrolled high blood pressure should not use almotriptan, as it can further increase blood pressure and exacerbate hypertension. - **Hemiplegic or Basilar Migraine**: Almotriptan is contraindicated in patients with hemiplegic or basilar migraine, as it can worsen symptoms and increase the risk of serious neurological events. - **Severe Hepatic Impairment**: Patients with severe liver disease should avoid almotriptan, as it is metabolized by the liver. Impaired liver function can lead to increased drug levels and toxicity. - **Severe Renal Impairment**: Patients with severe kidney disease should avoid almotriptan, as it is primarily eliminated by the kidneys. Impaired renal function can lead to drug accumulation and increased side effects. - **Concurrent Use with Ergot-Containing Drugs**: Almotriptan should not be used concurrently with ergot-containing drugs, as this can lead to increased side effects and reduced effectiveness of almotriptan. - **Concurrent Use with Other Triptans**: Almotriptan should not be used concurrently with other triptans, as this can increase the risk of side effects and reduce the effectiveness of almotriptan.

Side Effect

- **Common Side Effects**: The most common side effects of almotriptan include nausea, dizziness, drowsiness, and fatigue. These side effects are generally mild to moderate and may resolve over time. - **Cardiovascular Side Effects**: Almotriptan can cause serious cardiovascular side effects, including chest pain, tightness in the chest, and changes in heart rhythm. These side effects can be life-threatening and require immediate medical attention. - **Neurological Side Effects**: Almotriptan can cause neurological side effects, including headache, paresthesia (tingling or numbness), and seizures. These side effects can be more pronounced in patients with a history of neurological conditions. - **Gastrointestinal Side Effects**: Almotriptan can cause gastrointestinal side effects, including vomiting, diarrhea, and abdominal pain. These side effects are usually mild to moderate and may resolve over time. - **Psychiatric Side Effects**: Almotriptan can cause psychiatric side effects, including anxiety, depression, and insomnia. These side effects can be more pronounced in patients with a history of psychiatric conditions. - **Allergic Reactions**: Almotriptan can cause allergic reactions, including skin rash, itching, and anaphylaxis, a severe and potentially life-threatening reaction. Seek immediate medical attention if you experience these symptoms. - **Serotonin Syndrome**: Almotriptan can cause serotonin syndrome, a potentially life-threatening condition that occurs when there is too much serotonin in the brain. Symptoms include agitation, hallucinations, coma, and changes in blood pressure. - **Medication Overuse Headache**: Overuse of almotriptan can lead to medication overuse headache, a condition where frequent use of headache medications causes more headaches. It is important to follow the prescribed dosage and not exceed the recommended number of tablets per month. - **Visual Disturbances**: Almotriptan can cause visual disturbances, including blurred vision and changes in visual acuity. Regular eye examinations are essential while taking this medication. - **Musculoskeletal Side Effects**: Almotriptan can cause musculoskeletal side effects, including muscle weakness, joint pain, and back pain. These side effects are usually mild to moderate and may resolve over time.

Pregnancy Category ID

3

Mode of Action

- **Serotonin Receptor Agonist**: Almotriptan is a selective serotonin receptor agonist, specifically targeting the 5-HT1B and 5-HT1D receptors. By activating these receptors, almotriptan narrows blood vessels around the brain, stops pain signals from being sent to the brain, and blocks the release of certain natural substances that cause pain, nausea, and other migraine symptoms. - **Vasoconstriction**: Almotriptan works by causing vasoconstriction, or narrowing of blood vessels, in the brain. This action helps to alleviate migraine symptoms by reducing blood flow to the affected areas and preventing the dilation of blood vessels that contributes to migraine pain. - **Inhibition of Neurotransmitter Release**: Almotriptan inhibits the release of certain neurotransmitters, including substance P and calcitonin gene-related peptide (CGRP), which are involved in the transmission of pain signals during a migraine attack. By blocking the release of these neurotransmitters, almotriptan helps to reduce migraine symptoms. - **Central Nervous System Effects**: Almotriptan acts on the central nervous system to modulate pain pathways, reducing the perception of pain during a migraine attack. This action helps to alleviate migraine symptoms and improve the patient's ability to function. - **Selective Receptor Targeting**: Almotriptan's selective targeting of 5-HT1B and 5-HT1D receptors allows it to provide effective migraine relief with a lower risk of side effects compared to non-selective serotonin receptor agonists. This selectivity contributes to its safety and efficacy in treating migraines. - **Rapid Onset of Action**: Almotriptan has a rapid onset of action, providing relief from migraine symptoms within 30 minutes to 2 hours after administration. This quick action helps to alleviate migraine symptoms promptly, allowing patients to return to their daily activities. - **Duration of Action**: The effects of almotriptan typically last for several hours, providing sustained relief from migraine symptoms. This duration of action helps to prevent the recurrence of migraine symptoms and reduces the need for additional doses. - **Peripheral and Central Effects**: Almotriptan's mode of action involves both peripheral and central effects. Peripherally, it acts on blood vessels to reduce dilation and inflammation, while centrally, it modulates pain pathways to reduce the perception of pain. - **Neuroprotective Effects**: Almotriptan may have neuroprotective effects by reducing the inflammation and oxidative stress associated with migraine attacks. This action helps to protect neurons from damage and contributes to the overall efficacy of the medication. - **Modulation of Inflammatory Pathways**: Almotriptan modulates inflammatory pathways in the brain, reducing the release of pro-inflammatory cytokines and other mediators that contribute to migraine symptoms. This action helps to alleviate migraine symptoms and improve patient outcomes.

Interaction

- **Ergot-Containing Drugs**: Almotriptan should not be used concurrently with ergot-containing drugs, such as ergotamine or dihydroergotamine, as this can lead to increased side effects and reduced effectiveness of almotriptan. - **Other Triptans**: Almotriptan should not be used concurrently with other triptans, such as sumatriptan or rizatriptan, as this can increase the risk of side effects and reduce the effectiveness of almotriptan. - **Selective Serotonin Reuptake Inhibitors (SSRIs)**: Almotriptan can interact with SSRIs, such as fluoxetine or sertraline, increasing the risk of serotonin syndrome. This condition can be life-threatening and requires immediate medical attention. - **Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)**: Almotriptan can interact with SNRIs, such as venlafaxine or duloxetine, increasing the risk of serotonin syndrome. Close monitoring is essential when these medications are used together. - **Monoamine Oxidase Inhibitors (MAOIs)**: Almotriptan should not be used concurrently with MAOIs, such as phenelzine or tranylcypromine, as this can lead to a dangerous increase in blood pressure and other serious side effects. - **Antidepressants**: Almotriptan can interact with other antidepressants, including tricyclic antidepressants (TCAs) and newer antidepressants, increasing the risk of side effects. Close monitoring is essential when these medications are used together. - **Antipsychotics**: Almotriptan can interact with antipsychotics, such as haloperidol or risperidone, increasing the risk of side effects. Dose adjustments may be necessary when these medications are used together. - **Anticonvulsants**: Almotriptan can interact with anticonvulsants, such as carbamazepine or valproic acid, affecting their effectiveness or increasing the risk of side effects. Dose adjustments may be necessary when these medications are used together. - **Antihypertensive Drugs**: Almotriptan can interact with antihypertensive drugs, such as beta-blockers or ACE inhibitors, affecting blood pressure control. Close monitoring of blood pressure is essential when these medications are used together. - **Alcohol**: Alcohol can interact with almotriptan, increasing the risk of side effects, including dizziness and drowsiness. Avoid alcohol consumption while taking almotriptan.

Pregnancy Category Note

Information not available

Adult Dose

- **Acute Migraine Treatment**: The usual adult dose of almotriptan for acute migraine treatment is 6.25 mg to 12.5 mg taken at the first sign of a migraine headache. If symptoms improve but return after 2 hours, a second dose may be taken. However, if symptoms do not improve, do not take a second dose without consulting your doctor. - **Maximum Daily Dose**: The maximum daily dose of almotriptan is 25 mg. Do not exceed this dose in a 24-hour period to avoid the risk of side effects. Follow the prescribed dosage carefully and consult your doctor if you have any questions. - **Dose Adjustments for Renal Impairment**: For patients with mild to moderate renal impairment, the starting dose of almotriptan should be 6.25 mg. The dose may be adjusted based on individual response and tolerance. Patients with severe renal impairment should not use almotriptan. - **Dose Adjustments for Hepatic Impairment**: For patients with mild to moderate hepatic impairment, the starting dose of almotriptan should be 6.25 mg. The dose may be adjusted based on individual response and tolerance. Patients with severe hepatic impairment should not use almotriptan. - **Dose Adjustments for Elderly Patients**: Elderly patients may be more sensitive to the effects of almotriptan. The starting dose for elderly patients should be 6.25 mg. The dose may be adjusted based on individual response and tolerance. - **Dose Adjustments for Patients Taking Other Medications**: Patients taking other medications, such as SSRIs, SNRIs, or MAOIs, may require dose adjustments of almotriptan to avoid the risk of serotonin syndrome. Consult your doctor before taking almotriptan if you are taking any of these medications. - **Dose Adjustments for Patients with Cardiovascular Conditions**: Patients with cardiovascular conditions, such as high blood pressure or coronary artery disease, should use almotriptan with caution. The starting dose should be 6.25 mg, and the dose may be adjusted based on individual response and tolerance. Regular monitoring of heart health is essential while taking almotriptan. - **Dose Adjustments for Patients with a History of Seizures**: Patients with a history of seizures should use almotriptan with caution. The starting dose should be 6.25 mg, and the dose may be adjusted based on individual response and tolerance. Close monitoring is essential for these patients while taking almotriptan. - **Dose Adjustments for Patients with Renal or Hepatic Impairment**: Patients with renal or hepatic impairment should use almotriptan with caution. The starting dose should be 6.25 mg, and the dose may be adjusted based on individual response and tolerance. Regular monitoring of renal and hepatic function is essential while taking almotriptan. - **Dose Adjustments for Patients with Other Medical Conditions**: Patients with other medical conditions, such as diabetes or thyroid disorders, may require dose adjustments of almotriptan. Consult your doctor before taking almotriptan if you have any of these conditions.

Child Dose

- **Acute Migraine Treatment**: The usual dose of almotriptan for acute migraine treatment in adolescents aged 12 to 17 is 6.25 mg to 12.5 mg taken at the first sign of a migraine headache. If symptoms improve but return after 2 hours, a second dose may be taken. However, if symptoms do not improve, do not take a second dose without consulting your doctor. - **Maximum Daily Dose**: The maximum daily dose of almotriptan for adolescents is 25 mg. Do not exceed this dose in a 24-hour period to avoid the risk of side effects. Follow the prescribed dosage carefully and consult your doctor if you have any questions. - **Dose Adjustments for Renal Impairment**: For adolescents with mild to moderate renal impairment, the starting dose of almotriptan should be 6.25 mg. The dose may be adjusted based on individual response and tolerance. Regular monitoring of renal function is essential while taking almotriptan. - **Dose Adjustments for Hepatic Impairment**: For adolescents with mild to moderate hepatic impairment, the starting dose of almotriptan should be 6.25 mg. The dose may be adjusted based on individual response and tolerance. Regular monitoring of hepatic function is essential while taking almotriptan. - **Dose Adjustments for Patients Taking Other Medications**: Adolescents taking other medications, such as SSRIs, SNRIs, or MAOIs, may require dose adjustments of almotriptan to avoid the risk of serotonin syndrome. Consult your doctor before taking almotriptan if you are taking any of these medications. - **Dose Adjustments for Patients with Cardiovascular Conditions**: Adolescents with cardiovascular conditions, such as high blood pressure or coronary artery disease, should use almotriptan with caution. The starting dose should be 6.25 mg, and the dose may be adjusted based on individual response and tolerance. Regular monitoring of heart health is essential while taking almotriptan. - **Dose Adjustments for Patients with a History of Seizures**: Adolescents with a history of seizures should use almotriptan with caution. The starting dose should be 6.25 mg, and the dose may be adjusted based on individual response and tolerance. Close monitoring is essential for these patients while taking almotriptan. - **Dose Adjustments for Patients with Renal or Hepatic Impairment**: Adolescents with renal or hepatic impairment should use almotriptan with caution. The starting dose should be 6.25 mg, and the dose may be adjusted based on individual response and tolerance. Regular monitoring of renal and hepatic function is essential while taking almotriptan. - **Dose Adjustments for Patients with Other Medical Conditions**: Adolescents with other medical conditions, such as diabetes or thyroid disorders, may require dose adjustments of almotriptan. Consult your doctor before taking almotriptan if you have any of these conditions. - **Dose Adjustments for Younger Children**: Almotriptan is not recommended for children younger than 12 years of age due to a lack of safety and efficacy data in this age group. Consult your doctor for alternative treatment options if your child is younger than 12 years old.

Renal Dose

- **Mild to Moderate Renal Impairment**: For patients with mild to moderate renal impairment (creatinine clearance 30-50 mL/min), the starting dose of almotriptan should be 6.25 mg. The dose may be adjusted based on individual response and tolerance. Regular monitoring of renal function is essential while taking almotriptan. - **Severe Renal Impairment**: Patients with severe renal impairment (creatinine clearance less than 30 mL/min) should not use almotriptan due to the risk of accumulation and increased side effects. If use is necessary, close monitoring and further dose reduction may be required. - **End-Stage Renal Disease**: Almotriptan is generally not recommended for patients with end-stage renal disease (creatinine clearance less than 10 mL/min) due to the risk of accumulation and increased side effects. If use is necessary, close monitoring and individualized dosing are essential to avoid adverse effects. - **Dialysis**: There is limited information on the use of almotriptan in patients undergoing dialysis. If almotriptan is used in these patients, close monitoring and individualized dosing are essential to avoid adverse effects. - **Monitoring**: Regular monitoring of renal function is important in patients with renal impairment who are taking almotriptan. Dose adjustments should be made based on changes in renal function and individual response to the medication. - **Dose Adjustments**: Dose adjustments may be necessary based on individual response and tolerance. It is important to follow the prescribing healthcare provider's instructions for dose adjustments. In some cases, a lower starting dose may be recommended for patients with certain medical conditions. - **Special Considerations**: Patients with renal impairment may be more sensitive to the effects of almotriptan, particularly fluid retention and electrolyte imbalances. Close monitoring of fluid status and electrolyte levels is essential. - **Concomitant Medications**: Patients with renal impairment may be taking other medications that can interact with almotriptan. It is important to inform your doctor about all medications you are taking to avoid potential drug interactions. - **Hydration**: Adequate hydration is essential for patients with renal impairment who are taking almotriptan. Dehydration can exacerbate renal function and increase the risk of side effects. Regular fluid intake is recommended. - **Regular Check-Ups**: Regular medical check-ups are essential while taking almotriptan to monitor for side effects and ensure the medication is working as intended. This includes blood tests and physical examinations.

Administration

Information not available